CN106074988A - A kind of externally-used pain-relieving medical ointment prescription and manufacture method - Google Patents

A kind of externally-used pain-relieving medical ointment prescription and manufacture method Download PDF

Info

Publication number
CN106074988A
CN106074988A CN201610266512.1A CN201610266512A CN106074988A CN 106074988 A CN106074988 A CN 106074988A CN 201610266512 A CN201610266512 A CN 201610266512A CN 106074988 A CN106074988 A CN 106074988A
Authority
CN
China
Prior art keywords
accounts
radix aconiti
radix
externally
herba menthae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610266512.1A
Other languages
Chinese (zh)
Inventor
陈堃
陈人智
陈卫川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610266512.1A priority Critical patent/CN106074988A/en
Publication of CN106074988A publication Critical patent/CN106074988A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534Mentha (mint)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704Polygonum, e.g. knotweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708Rheum (rhubarb)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714Aconitum (monkshood)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/889Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of externally-used pain-relieving medical ointment prescription and manufacture method, formed by spreading French Franc, Herba Menthae, Flos Daturae, Radix Et Rhizoma Rhei, Rhizoma Polygoni Cuspidati, Radix Aconiti, Radix Aconiti Kusnezoffii and blood agglomeration synthetic sheet, compared with prior art, the present invention uses multiple Huis incense drug secret, it is evident in efficacy, effect is unique, easy to use, there is expelling wind and cold, removing obstruction from collaterals, promoting blood circulation and detumescence, raising immunity, the pharmacological action of strengthening vital QI to eliminate pathogenic factors, it is widely used in anemofrigid-damp arthralgia, limbs pain, numbness, acute soft tissue injury, the disease such as scapulohumeral periarthritis, cervical spondylosis, osteoarthritis, neuralgia.

Description

A kind of externally-used pain-relieving medical ointment prescription and manufacture method
Technical field
The present invention relates to a kind of pharmaceutical formulation, particularly relate to a kind of externally-used pain-relieving medical ointment prescription and manufacture method.
Background technology
Rheumatism is one group of infringement joint, skeleton, muscle, blood vessel and is main disease about soft tissue or connective tissue, Wherein majority is autoimmune disease.Morbidity is much more hidden and slow, and the course of disease is longer, and mostly has genetic predisposition.Diagnosis And treatment all acquires a certain degree of difficulty;How blood can check different autoantibodys, may be relevant from different HLA hypotypes;To non- Steroidal anti-inflammatory drugs (NSAID), glucocorticoid and immunosuppressant have preferable short-term or the reaction of long-term palliative.Existing skill Curative effect of medication in art is the most undesirable, accordingly, it would be desirable to a kind of new medicine is born.
Summary of the invention
The purpose of the present invention is that provides a kind of externally-used pain-relieving medical ointment prescription and making side to solve the problems referred to above Method.
The present invention is achieved through the following technical solutions above-mentioned purpose:
The present invention is formed by spreading French Franc, Herba Menthae, Flos Daturae, Radix Et Rhizoma Rhei, Rhizoma Polygoni Cuspidati, Radix Aconiti, Radix Aconiti Kusnezoffii and blood agglomeration synthetic sheet, described in spread French Franc accounts for 20%, described Herba Menthae accounts for 10%, described Flos Daturae accounts for 20%, described Radix Et Rhizoma Rhei accounts for 20%, described Rhizoma Polygoni Cuspidati accounts for 20%, described Radix Aconiti accounts for 10%, described Radix Aconiti Kusnezoffii accounts for 10%, described blood agglomeration synthetic sheet accounts for 10%.
The manufacture method of the present invention, it is characterised in that comprise the following steps:
(1) take qualified spread French Franc, Herba Menthae, Flos Daturae, Radix Et Rhizoma Rhei, Rhizoma Polygoni Cuspidati, Radix Aconiti, Radix Aconiti Kusnezoffii and blood agglomeration synthetic sheet and pass through pulverizing Reach the powder that mesh number is 120 mesh
(2) weighing vaseline stainless-steel pan slow fire heating 100-120 degree to melt, stir even rear stopping and heating, temperature drops To 70-80 spend time, slowly add the crude drug in whole that step (1) weighs and stir, with the length of side be 10 × 12cm centimetre just The mixture of the making of 10 grams of length of sides 10 × 12 centimetres, thickness 0.2-0.3 centimetre is wrapped up in square patch.
The beneficial effects of the present invention is:
The present invention is a kind of externally-used pain-relieving medical ointment prescription and manufacture method, and compared with prior art, the present invention uses multiple Huis incense drug secret, it is evident in efficacy, effect is unique, easy to use, has expelling wind and cold, removing obstruction from collaterals, promoting blood circulation and detumescence, raising Immunity, the pharmacological action of strengthening vital QI to eliminate pathogenic factors, be widely used in anemofrigid-damp arthralgia, limbs pain, numbness, acute soft tissue injury, scapulohumeral periarthritis, The diseases such as cervical spondylosis, osteoarthritis, neuralgia.
Detailed description of the invention
The invention will be further described below:
The present invention is formed by spreading French Franc, Herba Menthae, Flos Daturae, Radix Et Rhizoma Rhei, Rhizoma Polygoni Cuspidati, Radix Aconiti, Radix Aconiti Kusnezoffii and blood agglomeration synthetic sheet, described in spread French Franc accounts for 20%, described Herba Menthae accounts for 10%, described Flos Daturae accounts for 20%, described Radix Et Rhizoma Rhei accounts for 20%, described Rhizoma Polygoni Cuspidati accounts for 20%, described Radix Aconiti accounts for 10%, described Radix Aconiti Kusnezoffii accounts for 10%, described blood agglomeration synthetic sheet (Sanguis Draxonis, Borneolum Syntheticum) accounts for 10%.
The manufacture method of the present invention, it is characterised in that comprise the following steps:
(1) take qualified spread French Franc, Herba Menthae, Flos Daturae, Radix Et Rhizoma Rhei, Rhizoma Polygoni Cuspidati, Radix Aconiti, Radix Aconiti Kusnezoffii and blood agglomeration synthetic sheet and pass through pulverizing Reach the powder that mesh number is 120 mesh
(2) weighing vaseline stainless-steel pan slow fire heating 100-120 degree to melt, stir even rear stopping and heating, temperature drops To 70-80 spend time, slowly add the crude drug in whole that step (1) weighs and stir, with the length of side be 10 × 12cm centimetre just The mixture of the making of 10 grams of length of sides 10 × 12 centimetres, thickness 0.2-0.3 centimetre is wrapped up in square patch.
The ultimate principle of the present invention and principal character and advantages of the present invention have more than been shown and described.The technology of the industry Personnel, it should be appreciated that the present invention is not restricted to the described embodiments, simply illustrating this described in above-described embodiment and description The principle of invention, without departing from the spirit and scope of the present invention, the present invention also has various changes and modifications, and these become Change and improvement both falls within scope of the claimed invention.Claimed scope by appending claims and Equivalent defines.

Claims (2)

1. an externally-used pain-relieving medical ointment prescription, it is characterised in that: by spreading French Franc, Herba Menthae, Flos Daturae, Radix Et Rhizoma Rhei, Rhizoma Polygoni Cuspidati, Radix Aconiti, grass Crow and blood agglomeration synthetic sheet form, described in spread that French Franc accounts for 20%, described Herba Menthae accounts for 10%, described Flos Daturae accounts for 20%, described Radix Et Rhizoma Rhei Account for 20%, described Rhizoma Polygoni Cuspidati accounts for 20%, described Radix Aconiti accounts for 10%, described Radix Aconiti Kusnezoffii accounts for 10%, described blood agglomeration synthetic sheet accounts for 10%.
The manufacture method of externally-used pain-relieving ointment the most according to claim 1, it is characterised in that comprise the following steps:
(1) take qualified spread French Franc, Herba Menthae, Flos Daturae, Radix Et Rhizoma Rhei, Rhizoma Polygoni Cuspidati, Radix Aconiti, Radix Aconiti Kusnezoffii and blood agglomeration synthetic sheet to reach through pulverizing Mesh number is the powder of 120 mesh
(2) weighing vaseline stainless-steel pan slow fire heating 100-120 degree to melt, stir even rear stopping and heating, temperature drops to 70- When 80 degree, slowly add the crude drug in whole that step (1) weighs and stir, by the positive square patch that the length of side is 10 × 12cm centimetre Cloth wraps up the mixture of the making of 10 grams of length of sides 10 × 12 centimetres, thickness 0.2-0.3 centimetre.
CN201610266512.1A 2016-04-26 2016-04-26 A kind of externally-used pain-relieving medical ointment prescription and manufacture method Pending CN106074988A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610266512.1A CN106074988A (en) 2016-04-26 2016-04-26 A kind of externally-used pain-relieving medical ointment prescription and manufacture method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610266512.1A CN106074988A (en) 2016-04-26 2016-04-26 A kind of externally-used pain-relieving medical ointment prescription and manufacture method

Publications (1)

Publication Number Publication Date
CN106074988A true CN106074988A (en) 2016-11-09

Family

ID=58702477

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610266512.1A Pending CN106074988A (en) 2016-04-26 2016-04-26 A kind of externally-used pain-relieving medical ointment prescription and manufacture method

Country Status (1)

Country Link
CN (1) CN106074988A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1205887A (en) * 1997-07-20 1999-01-27 刘灵 Pain relieving ointment
CN104189345A (en) * 2014-09-01 2014-12-10 孙广军 Externally applied traditional Chinese medicine plaster for treating aching diseases
CN104436103A (en) * 2014-11-06 2015-03-25 王全文 External rheumatalgia-relieving bone penetrating plaster and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1205887A (en) * 1997-07-20 1999-01-27 刘灵 Pain relieving ointment
CN104189345A (en) * 2014-09-01 2014-12-10 孙广军 Externally applied traditional Chinese medicine plaster for treating aching diseases
CN104436103A (en) * 2014-11-06 2015-03-25 王全文 External rheumatalgia-relieving bone penetrating plaster and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101244252B (en) Chinese medicine label for eliminating ache and preparation thereof
CN102363037B (en) Externally applied plaster for treating rheumatism, rheumatoid arthritis and neck-shoulder and lumbocrural pain
CN102648934A (en) Traditional Chinese medicine composition for treating chronic simple rhinitis and preparation method thereof
CN103656027A (en) External-application plaster for treating hyperosteogeny
CN104127730A (en) Traditional Chinese medicine for treating neurasthenia and preparation method thereof
CN105214043A (en) A kind of neck, shoulder, waist and leg energy pastes and preparation method thereof
CN103230487A (en) Plaster for bone disease treatment
CN1586504A (en) Paste for promoting blood circulation to stop pain
CN103933129A (en) Plaster for treating pain
CN106074988A (en) A kind of externally-used pain-relieving medical ointment prescription and manufacture method
CN104800722A (en) Pharmaceutical composition, preparation and preparation method of composition
CN104547825B (en) A kind of preparation method for the Chinese medicine composition and its preparation for treating myoneural pain
CN103182061B (en) Plaster for treating cervical spondylosis and lumbar diseases
CN101336990B (en) Medicine for treating cholecystitis
CN106074923A (en) The pharmaceutical formulation of a kind for the treatment of of arthritis and manufacture method
CN104147007B (en) A kind of for analgesic medical composition and its use
CN103340945A (en) Drug for treating acne
CN103239689B (en) Chinese medicine preparation for treating chronic cholecystitis
CN102698012B (en) Externally applied traditional Chinese medicine for treating oral lichen planus
CN103169927B (en) Traditional Chinese medicine preparation for treating chronic cholecystitis
CN103157053A (en) Pain-relieving traditional Chinese medicine preparation and preparation method thereof
CN106822586A (en) One kind treats neurasthenic Chinese medicine
CN105902843A (en) Ointment capable of treating traumatic injury
CN102755466B (en) A kind of thing that puts drops in one's ear treating acute suppurative otitis media
CN105726718A (en) A traditional Chinese medicine for treating lumbago caused by traumatic injuries

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20161109

RJ01 Rejection of invention patent application after publication